Patents/Assignees

ASTELLAS PHARMA Inc.

25 patents in portfolio

US11679166utility2023
Anti-human MUC1 Antibody Fab Fragment
0 cites
US11672851utility2023
Ny-eso-1-containing Artificial Adjuvant Vector Cell for Use in Treatment of Cancer
0 cites
US11667724utility2023
Anti-human CEACAM5 Antibody Fab Fragment
0 cites
US11638730utility2023
Cancer Therapy by Combination Use of Oncolytic Vaccinia Virus and Immune Checkpoint Inhibitor, and Pharmaceutical Composition and Combination Medicine for Use in the Cancer Therapy
0 cites
US11578067utility2023
Compound, and Method for Producing Regulatory T Cells
0 cites

← PreviousPage 2 of 2